CCAP · Crescent Capital BDC, Inc. · Insider Trading

The shares were sold in multiple transactions at prices ranging from $10.18 to $10.28 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Represents shares of common stock held by Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the Reporting Person.

The shares were sold in multiple transactions at prices ranging from $10.285 to $10.45 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Represents shares of common stock held by Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the Reporting Person.

The shares were sold in multiple transactions at prices ranging from $10.36 to $10.43 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Represents shares of common stock held by Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the Reporting Person.

The shares were sold in multiple transactions at prices ranging from $10.31 to $10.38 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Represents shares of common stock held by Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the Reporting Person.

The shares were sold in multiple transactions at prices ranging from $10.38 to $10.51 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Represents shares of common stock held by Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the Reporting Person.

The shares were sold in multiple transactions at prices ranging from $10.48 to $10.59 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Represents shares of common stock held by Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the Reporting Person.

The shares were sold in multiple transactions at prices ranging from $10.51 to $10.70 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Represents shares of common stock held by Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the Reporting Person.

The shares were sold in multiple transactions at prices ranging from $10.53 to $10.655 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Represents shares of common stock held by Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the Reporting Person.

The shares were sold in multiple transactions at prices ranging from $10.60 to $10.67 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Represents shares of common stock held by Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the Reporting Person.

The shares were sold in multiple transactions at prices ranging from $10.60 to $10.625 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Represents shares of common stock held by Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the Reporting Person.

The shares were sold in multiple transactions at prices ranging from $10.74 to $10.80 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Represents shares of common stock held by Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the Reporting Person.

The shares were sold in multiple transactions at prices ranging from $10.72 to $10.77 per share. The price reported reflects the volume weighted average price for the transactions. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Represents shares of common stock held by Fidelity & Guaranty Life Insurance Company of New York, a wholly owned subsidiary of the Reporting Person.

Includes 1,137 shares acquired through dividend reinvestment in 2026 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.90 to $10.92, inclusive. Upon request by the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, the reporting person undertakes to provide full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Includes 695 shares acquired through dividend reinvestment in 2026 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

Includes 945 shares acquired through dividend reinvestment in 2026 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.11 to $11.35, inclusive. Upon request by the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, the reporting person undertakes to provide full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

1. Includes 2,088 shares acquired through dividend reinvestment in 2026 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

Includes 953 shares acquired through dividend reinvestment in 2025 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

Includes 639 shares acquired under the Dividend Reinvestment Plan of Crescent Capital BDC, Inc. in 2025 and not previously reported pursuant to Rule 16a-11 under the Securities Exchange Act of 1934.

Includes 2,556 shares acquired under the Dividend Reinvestment Plan of Crescent Capital BDC, Inc. in 2025 and not previously reported pursuant to Rule 16a-11 under the Securities Exchange Act of 1934.

Includes 32 shares acquired through dividend reinvestment in 2025 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

Includes 227 shares acquired through dividend reinvestment in 2025 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

Includes 1,917 shares acquired under the Dividend Reinvestment Plan of Crescent Capital BDC, Inc. in 2025 and not previously reported pursuant to Rule 16a-11 under the Securities Exchange Act of 1934.

Includes 12,779 shares acquired under the Dividend Reinvestment Plan of Crescent Capital BDC, Inc. in 2025 and not previously reported pursuant to Rule 16a-11 under the Securities Exchange Act of 1934.

Includes 575 shares acquired through dividend reinvestment in 2025 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

Includes 766 shares acquired through dividend reinvestment in 2025 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.34 to $13.3499, inclusive. Upon request by the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, the reporting person undertakes to provide full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Includes 2,627 shares acquired through dividend reinvestment in 2025 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

Includes 64 shares acquired through dividend reinvestment in 2025 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

Includes 1,181 shares acquired through dividend reinvestment in 2025 and not previously reported pursuant to Rule 16a-11 under the Securites Act of 1934.

Includes 2,187 shares acquired under the Dividend Reinvestment Plan of Crescent Capital BDC, Inc. in 2024 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

Includes 632 shares acquired through dividend reinvestment in 2024 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

Includes 547 shares acquired under the Dividend Reinvestment Plan of Crescent Capital BDC, Inc. in 2024 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

Includes 1,1041 shares acquired through dividend reinvestment in 2024 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

Includes 1,641 shares acquired under the Dividend Reinvestment Plan of Crescent Capital BDC, Inc. in 2024 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

Includes 73 shares acquired through dividend reinvestment in 2024 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

Includes 2,747 shares acquired through dividend reinvestment in 2024 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

Includes 187 shares acquired through dividend reinvestment in 2024 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

Includes 10,937 shares acquired under the Dividend Reinvestment Plan of Crescent Capital BDC, Inc. in 2024 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

Includes 1,495 shares acquired under the Dividend Reinvestment Plan of Crescent Capital BDC, Inc. in 2023 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

Includes 9,968 shares acquired under the Dividend Reinvestment Plan of Crescent Capital BDC, Inc. in 2023 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

Includes 86 shares acquired under the Dividend Reinvestment Plan of Crescent Capital BDC, Inc. in 2023 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

Includes 71 shares acquired under the Dividend Reinvestment Plan of Crescent Capital BDC, Inc. in 2023 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.

Includes 1,994 shares acquired under the Dividend Reinvestment Plan of Crescent Capital BDC, Inc. in 2023 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.